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The AIM2 inflammasome is a key cytosolic signaling
complex that is activated by double-stranded DNA,
leading to the maturation of proinflammatory cyto-
kines such as interleukin-1b (IL-1b) and IL-18. Dysre-
gulated AIM2 inflammasome activity is associated
with human inflammatory diseases and cancers, sug-
gesting that itsactivitymustbe tightly regulated.How-
ever, the precise molecular mechanisms that control
AIM2 levels and activity are still poorly understood.
Here, we report tripartite motif 11 (TRIM11) as a key
negative regulator of the AIM2 inflammasome. Upon
DNA virus infection, TRIM11 binds to AIM2 via its PS
domain and undergoes auto-polyubiquitination at
K458 to promote an association between TRIM11
and the autophagic cargo receptor p62 to mediate
AIM2 degradation via selective autophagy. These
findings identify a role for TRIMs in AIM2 inflamma-
some activation where TRIM11 acts as a secondary
receptor to deliver AIM2 to the autophagosomes for
degradation in a p62-dependent manner.
INTRODUCTION
The continuous surveillance of intracellular milieu is critical for
all metazoa to detect and respond to foreign DNA during micro-
bial infection, leading to initiation of a series of signaling events
that induce the production of type I interferons (IFNs) (including
IFN-b and IFN-a family members) and pro-inflammatory cyto-
kines. This defense mechanism depends on the identification
of pathogen-associated molecular patterns (PAMPs) by pattern
recognition receptors (PRRs) (Goubau et al., 2013). Up to now,
more than 15 DNA sensors have been reported (Paludan and
Bowie, 2013). Although many sensors, including TLR9, DAI,
and cGAS, have been shown to activate NF-kB or type-I IFN
signaling in response to viral DNA (Hemmi et al., 2000; Sun
et al., 2013; Takaoka et al., 2007), AIM2 (absent in melanoma
2) and IFI16 (interferon gamma-inducible protein 16) are the
only DNA sensors known to initiate the activation of inflamma-1988 Cell Reports 16, 1988–2002, August 16, 2016 ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://some against DNA virus infection (Fernandes-Alnemri et al.,
2009; Hornung et al., 2009; Krieg, 2009).
Inflammasomes are molecular platforms activated upon
cellular infection or stress that trigger the activation of the
cysteine protease caspase-1, which leads to the maturation
and secretion of the pro-inflammatory cytokines interleukin-1b
(IL-1b) and IL-18 (Ruland, 2014). Inflammasome assembly re-
quires the protein ASC (apoptosis-associated speck-like protein
containing a CARD), caspase-1/caspase-11, and scaffold pro-
teins. Most of the scaffold proteins are Nod-like receptors
(NLRs), such as NLRP1, NLRP3, NLRP6, and NLRC4 (Broderick
et al., 2015). However, AIM2 and IFI16 have been shown to
trigger the formation of inflammasome against foreign DNA in
the cytosol or nucleus, respectively (Jin et al., 2012). AIM2 is
an IFN-inducible cytosolic protein containing pyrin (PYD) and
hematopoietic interferon-inducible nuclear antigens with 200-
amino-acid repeat (HIN200) domains (B€urckst€ummer et al.,
2009; Landolfo et al., 1998). In quiescent conditions, an intramo-
lecular complex of the AIM2 PYD and HIN domains is in an auto-
inhibited state and liberated by DNA binding along the DNA
staircase when AIM2 inflammasome is activated (Jin et al.,
2012). The dysregulated AIM2 inflammasome activity has been
implicated in a variety of diseases, such as vascular inflamma-
tion, psoriasis, pyogenic arthritis, pyoderma gangrenosum, and
cryopyrin-associated periodic syndromes (CAPS) (Shaw and
Liu, 2014). However, the precise regulation of AIM2 inflamma-
some is still poorly understood. Here, we show that TRIM11
acts as a negative regulator tomediate AIM2 degradation to con-
trol inflammasome activation during DNA virus infection.
Tripartite motif (TRIM) proteins comprise a large family of pro-
teins based on a conserved domain architecture (known as
RBCC) that is characterized by a RING finger domain, one or
twoB-box domains, a coiled-coil domain, and a variable C termi-
nus (Reymond et al., 2001), and they play critical roles in the
regulation of multiple signaling pathways in innate immunity. It
has been reported that autophagy accompanies inflammasome
activation to temper inflammation by eliminating active inflam-
masome components (Saiga et al., 2015; Shi et al., 2012).
Recently, several studies reported that TRIMs are associated
with autophagy by acting as platforms to assemble ULK1 and
Beclin-1 and using their PS or other cargo-recognition domains
for the autophagic targeting of a wide variety of microbial andr(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. TRIM11 Inhibits AIM2, but Not NLRP3, Inflammasome Activation
(A and B) HEK293T cells were transiently transfected with TRIM expression vector plasmids alongwith AIM2 (A) or NLRP3 (B), ASC, pro-caspase-1, and pro-IL-1b
plasmid. Cell culture supernatants were collected 24 hr post-transfection to measure IL-1b release by ELISA.
(C) Schematic overview of the TetON system. Shown are results of the immunoblot analysis of protein extracts of HA-tagged TRIM11-inducible THP-1 cells
treated with increasing doses of doxycycline (Dox) for 24 hr.
(legend continued on next page)
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endogenous cellular substrates. TRIM20 acts as a platform for
autophagic proteins assembly, and targets inflammasome com-
ponents, including NLRP3, NLRP1, and pro-caspase-1, for auto-
phagic degradation (Kimura et al., 2015, 2016; Mandell et al.,
2014a, 2014b).
In this study, we identify a mechanism by which TRIM11 nega-
tively regulates AIM2 inflammasome activity. TRIM11 interacts
with AIM2 for its degradation upon DNA virus infection. Overex-
pression of TRIM11 in macrophages specially inhibits AIM2
inflammasome activation. Knockdown or knockout of TRIM11
enhances AIM2, but not NLRP3, inflammasome activation at
post-translational level in vitro and in vivo. Furthermore, we
find that TRIM11 undergoes auto-polyubiquitination on its lysine
(K) 458 to promote interaction between TRIM11 and the auto-
phagic cargo receptor p62 and to mediate AIM2 for degradation
via selective autophagy. Therefore, TRIM11 is a negative regu-
lator of AIM2 inflammasome activation by promoting AIM2
degradation in a p62-dependent manner. Hence, our findings
provide an insight into the mechanisms of tight regulation of in-
flammasome through its crosstalk with autophagy.
RESULTS
TRIM11 Inhibits AIM2-Induced, but Not NLRP3-Induced,
Inflammasome Activation
In an attempt to identify possible regulatory roles for TRIM family
members in inflammasome activation, we reconstituted AIM2
and NLRP3 inflammasome in HEK293T human embryonic kid-
ney cells (293T) by introducing the expression vectors of ASC,
pro-caspase-1, pro-IL-1b, AIM2, or NLRP3, respectively, as
well as one of 32 candidate genes encoding TRIMs. Among
them, we identified TRIM11 as a potent negative regulator that
specifically modulated the activation of AIM2 inflammasome,
but not NLRP3 inflammasome (Figures 1A and 1B). To assess
whether TRIM11 was able to inhibit AIM2 inflammasome activa-
tion in human macrophages, we established a doxycycline
(Dox)-inducible TRIM11-overexpressing THP-1 cell line using
the TetON system (Figure 1C), and hemagglutinin (HA)-tagged
TRIM11 could be readily detected at 24 hr after Dox treatment.
We next pretreated TRIM11-inducible THP-1-derived macro-
phages with or without Dox for 24 hr, followed by treatment
with different kinds of ligands for AIM2 and NLRP3 inflamma-
some, respectively. We found that TRIM11 markedly inhibited
IL-1b secretion induced by poly(dA:dT) treatment or herpes sim-
plex virus 1 (HSV-1) infection (Figure 1D). However, the IL-1b
secretion induced by NLRP3 activators, including crystalline
stimulations (alum, calcium pyrophosphate dihydrate [CPPD],
and silica) or noncrystalline stimulations (poly(I:C), nigericin
[Nig], ATP, and MDP), was comparable between control and
TRIM11-overexpressing macrophages (Figure 1D). Consistent(D) TRIM11-inducible THP-1 cells were pre-incubated in culture medium with 100
then stimulated with poly(dA:dT) (1 mg/ml, 6 hr) or HSV-1 infection (MOI = 0.1, 12 h
(7.5 mM, 45 min), ATP (5 mM, 6 hr), alum (300 mg/ml, 6 hr), CPPD (50 mg/ml, 6 hr), s
were collected to measure IL-1b release by ELISA.
(E and F) TRIM11-inducible THP-1 cells were treated as in (D), and the cell lysate
Data in (A), (B), and (D) are presented as the mean ± SD of three independent expe
treatment (Student’s t test).
1990 Cell Reports 16, 1988–2002, August 16, 2016with these results, we found AIM2 inflammasome was sup-
pressed, as less cleaved caspase-1 and IL-1b were detected
in TRIM11-overexpressing macrophages with AIM2 activators
such as poly(dA:dT) or HSV-1 (Figure 1E), but not NLRP3 activa-
tors, including poly(I:C) or alum (Figure 1F). Therefore, these re-
sults indicate that TRIM11 specially inhibits AIM2-induced, but
not NLRP3-induced, inflammasome activation.
TRIM11 Deficiency Enhances AIM2 Inflammasome
Activation
To examine whether TRIM11 was involved in the negative
regulation of AIM2 inflammasome activation in physiological
conditions, we used two TRIM11-specific small interfering
RNAs (siRNAs) to knock down the expression of TRIM11. Both
of them efficiently inhibited the expression of endogenous
TRIM11 as compared with control siRNA in THP-1 cells (Fig-
ure S1A). We next assessed the effects of TRIM11 knockdown
(KD) on the activation of different kinds of inflammasomes by
measuring the secretion of IL-1b and found that TRIM11 KD
potentiated poly(dA:dT) and HSV-1-triggered activation of
AIM2 inflammasome (Figure 2A). In contrast, TRIM11 KD did
not affect NLRP3 inflammasome activation induced by alum,
MSU, CPPD, silica, poly(I:C), nigericin, or ATP (Figure 2B). To
exclude the possibility that TRIM11 inhibits IL-1b secretion at
the transcriptional level, we checked the mRNA level of tumor
necrosis factor a (TNF-a), IL-6, and IL-1b in TRIM11-silenced
cells or control cells and found that knockdown of TRIM11 had
no effect on themRNA abundance of these pro-inflammatory cy-
tokines (Figures S1B–S1D). Furthermore, we found that knock-
down of TRIM11 resulted in more cleaved caspase-1 as well
as IL-1b in the supernatant of the THP-1 macrophages treated
with poly(dA:dT) or HSV-1 (Figure 2C), but not alum or poly(I:C)
(Figure S1E). Together, these results suggest that knockdown
of TRIM11 enhances AIM2, but not NLRP3, inflammasome acti-
vation at the post-translational level.
To further demonstrate whether TRIM11 deficiency selectively
promoted AIM2 inflammasome activation, we generated
TRIM11 knockout (KO) THP-1 cells by CRISPR/Cas9 technology
(Figures S1F and S1H) and found that secretion of IL-1b as well
as caspase-1 cleavage was substantially increased in TRIM11-
KO macrophages following poly(dA:dT) stimulation or HSV-1
infection (Figures 2D and S1G). We did not observe any appre-
ciable difference in release of IL-1b or caspase-1 cleavage be-
tween TRIM11-KO and control cells after stimulation of many
NLRP3 activators (Figure S1I). It has been reported that besides
AIM2, IFI16 could also recognize DNA from vaccinia virus and
HSV-1 to activate immune response (Xiao, 2015). To investigate
a potential effect on IFI16 by TRIM11, we used siRNAs to knock
down endogenous IFI16 or AIM2 in THP-1-derivedmacrophages
to investigate whether the downregulation of inflammasomeng/ml PMA overnight and subsequently treated with Dox for 24 hr. Cells were
r) or pre-treated with LPS (100 ng/ml) for 3 hr before poly(I:C) (2 mg/ml, 6 hr), Nig
ilica (500 mg/ml, 6 hr), or MDP (20 mg/ml, 6 hr). NT, untreated. Cell supernatants
s and culture supernatants were collected for immunoblot.
riments. **p < 0.01 and ***p < 0.001 versus control cells subjected to the same
Figure 2. TRIM11 Deficiency Enhances AIM2 Inflammasome Activation
(A and B) THP-1-derivedmacrophageswere transfectedwith control siRNA or TRIM11 siRNA using Lipofectamine RNAiMAX for 48 hr. Cells were then stimulated
with poly(dA:dT) (1 mg/ml, 6 hr) or HSV-1 infection (MOI = 0.1, 12 hr) or pre-treatedwith LPS (100 ng/ml) for 3 hr before poly (I:C) (2 mg/ml, 6 hr), Nig (7.5 mM, 45min),
(legend continued on next page)
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activation mediated by TRIM11 was IFI16 or AIM2 dependent
(Figure S1J). We observed that TRIM11 deficiency could still
enhance the secretion of IL-1b and IL-18 and trigger cell death
in response to poly(dA:dT) and HSV-1 in IFI16-KD cells, but not
in AIM2 knockdown cells (Figures 2E and 2F). Similar results
were obtained using primary mouse bone-marrow-derived mac-
rophages (BMDMs) or bone marrow dendritic cells (BMDCs)
after Trim11 KD using specific single guide (sg)RNA through
CRISPR/Cas9 technology (Figures S1K and S1L). These results
indicate that TRIM11 deficiency selectively enhances AIM2 in-
flammasome activation in macrophages and DCs.
TRIM11 Inhibits AIM2 Inflammasome Activation In Vivo
Given that TRIM11 inhibits AIM2 inflammasome activation
in vitro,wenext determined the biological effect of TRIM11 in vivo
by knocking down TRIM11 in mice. We infected bone marrow
(BM) cells with a lentivirus carryingGFP sgRNA or Trim11 sgRNA
and intravenously injected the infected BM cells into 6-week-old
irradiated B6 wild-type (WT) mice to generate Trim11-KD
chimeric mice (Figure S1M). The mice were then challenged
with mouse cytomegalovirus (mCMV). We found that IL-1b and
IL-18 secretion in the sera was significantly increased by in vivo
Trim11 KD, which was in line with the observation in vitro (Fig-
ure 2G). In addition, the release of IL-6 and TNF-a were compa-
rable between the control group and the Trim11 sgRNA group,
suggesting the effect of TRIM11 on IL-1b production is not due
to elevation of the overall inflammation status (Figure 2G). We
also observed decreased mCMV virus titer in spleen in Trim11-
KD chimeric mice compared with GFP sgRNA reconstituted
mice (Figure 2H). Furthermore, we collected BMDMs from
GFP sgRNA or Trim11 sgRNA reconstituted mice and found
that TRIM11 deficiency enhanced caspase-1 processing when
BMDMs were infected with mCMV (Figure S1N). These findings
further demonstrate that TRIM11 directly inhibits AIM2 inflam-
masome activation in vivo.
TRIM11 Interacts with AIM2
To investigate whether TRIM11 directly targets the components
of AIM2 inflammasome to inhibit its activation, we co-trans-
fected 293T cells with expression vector containing AIM2, or
ASC together with TRIM11, and found that TRIM11 directly
interacted with AIM2, but not with its adaptor protein, ASC
(Figure 3A). Confocal microscopic analysis further confirmed
that TRIM11 co-localized with AIM2 in the cytosol (Figure 3B).ATP (5 mM, 6 hr), alum (300 mg/ml, 6 hr), CPPD (50 mg/ml, 6 hr), silica (500 mg/m
collected to measure IL-1b release by ELISA.
(C) THP-1 derived macrophages were treated with indicated stimuli and cell lysa
(D) THP-1 derived macrophages were infected with control sgRNA or TRIM11 s
collected to measure the IL-1b release by ELISA.
(E and F) Wild-type (WT) or TRIM11 knockout (KO) THP-1 macrophages were tran
stimulated by HSV-1 (MOI = 0.1, 24 hr) (F) or poly(dA:dT) (1 mg/ml, 6 hr) (E), and
ELISA. Cell death was measured by LDH (lactate dehydrogenase) release.
(G) Measurement of IL-1b, IL-18, TNF-a, and IL-6 in sera of the TRIM11-KD chim
mouse) infection for 36 hr.
(H) Measurement of mCMV titer in spleen of the Trim11-KD chimeric mice challe
Data in (A), (B), (D), and (E)–(H) are presented as the means ± SD of three indepe
subjected to the same treatment (Student’s t test).
See also Figure S1.
1992 Cell Reports 16, 1988–2002, August 16, 2016Interestingly, we found that the interaction between HA-tagged
TRIM11 and endogenous AIM2 was markedly increased after
poly(dA:dT) treatment in TRIM11-overexpressing THP-1 cells
(Figure 3C). To further examine the interaction between
TRIM11 and AIM2 after stimulation under physiological con-
ditions, we treated mouse macrophages or human periph-
eral blood mononuclear cells (PBMCs) with poly(dA:dT) and
collected the lysates. Consistent with our observation in THP-1
cells, we found that the TRIM11-AIM2 interaction became stron-
ger after poly(dA:dT) treatment in both mouse macrophages and
PBMCs (Figures 3D and 3E). These results indicate that TRIM11
interacts with AIM2 in a stimuli-enhanced manner after foreign
DNA stimulation.
To further determine which domain of AIM2 is responsible for
interacting with TRIM11, we generated AIM2-PYD domain and
AIM2-HIN domain deletion mutants and found that both two do-
mains of AIM2 bound to TRIM11 (Figure 3F). Next, we examined
which TRIM11 domains are responsible for interacting with
AIM2. Four truncated mutants were constructed: TRIM11/
BBCC with a BBCC domain only, TRIM11/PS with a PS domain
only, TRIM11/DRING lacking the RING domain, and TRIM11/
DBBCC lacking a BBCC domain (Figure 3G, top). Co-immuno-
precipitation (coIP) experiments with these truncated mutants
revealed that TRIM11/BBCC lost the ability to bind with AIM2,
while other mutants did not (Figure 3G, bottom). These results
suggest that TRIM11 binds to AIM2 through its PS domain.
TRIM11 Induces AIM2 Degradation
During the coIP experiments, we repeatedly observed that AIM2
expression was much lower after Dox treatment in TRIM11-
inducible THP-1-derived macrophages (Figure 3C). This finding
prompted us to investigate the effect of TRIM11 on AIM2 abun-
dance. We found that increasing amounts of TRIM11 led to a
considerable loss of overexpressed AIM2 protein (Figure 4A),
but not of any other proteins (Figure S2). RT-PCR showed that
AIM2 mRNA abundance was not altered with TRIM11 overex-
pression (Figure 4A), which suggested that the decrease in
AIM2 expression occurred at the protein level. In addition, we
performed a cycloheximide (CHX) ‘‘chase’’ assay to show that
TRIM11 deficiency led to a longer half-life of exogenous AIM2
(Figure 4B). Next, we assessed whether TRIM11 is able to
mediate degradation of endogenous AIM2 under physiological
conditions and found that endogenous AIM2 was not changed
in TRIM11-inducible THP-1 cells treated with Dox alonel, 6 hr), or MSU (300 mg/ml, 6 hr). NT, untreated. Culture supernatant was then
tes and supernatants were collected for immunoblot.
gRNA and then challenged with indicated stimuli. Cell supernatant was then
sfected with control siRNA or AIM2 siRNA or IFI16 siRNA for 48 hr. Cells were
culture supernatant was then collected to measure IL-18 and IL-1b release by
eric mice challenged with mouse cytomegalovirus (mCMV) (1 3 106 PFU per
nged with mCMV (1 3 106 PFU per mouse) infection for 36 hr in vivo.
ndent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 versus control cells
Figure 3. TRIM11 Interacts with AIM2
(A) HEK293T cells were transfected with plasmids expressing FLAG-AIM2, FLAG-ASC, and HA-TRIM11, then treated with 20mM ammonium chloride (NH4Cl) for
6 hr. Whole-cell lysates were harvested for immunoprecipitation (IP) with anti-FLAG beads and immunoblot analysis with anti-HA. WCL, immunoblot analysis of
whole-cell lysates without immunoprecipitation (throughout).
(B) HeLa cells were transfected with GFP-AIM2 or RFP-TRIM11 for 24 hr, then challenged with NH4Cl (20 mM) for 6 hr. Subsequently, cells were fixed with 4%
(wt/vol) paraformaldehyde and subjected for confocal microscopy. Scale bars, 20 mm.
(C) TRIM11-inducible THP-1 macrophages were treated with doxycycline (Dox) (100 ng/ml) for 24 hr, then challenged with poly(dA:dT) (1 mg/ml) for 6 hr. Cell
extracts were collected for immunoprecipitation with anti-HA followed by immunoblot (IB) with anti-AIM2 antibody.
(legend continued on next page)
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(Figure 4C). Furthermore, we found that overexpression of
TRIM11 only led to much lower levels of AIM2 protein, but not
ASC protein, after poly(dA:dT) stimulation (Figure 4C). Con-
versely, KD or KO of TRIM11 resulted in much higher levels of
endogenous AIM2, but not ASC, in THP-1 derived macrophages
transfected with poly(dA:dT) (Figures 4D and 4E). To evaluate the
contribution of different domains of TRIM11 to AIM2 degrada-
tion, we co-transfected HEK293T cells with FLAG-AIM2 and
HA-tagged TRIM11 truncates. Immunoblot analysis suggested
loss of any domain in TRIM11 impaired its ability to degrade
AIM2 (Figure 4F). Together, these findings indicate that the integ-
rity of TRIM11 is critical to induce AIM2 degradation, especially
after poly(dA:dT) stimulation.
TRIM11 Mediates Autophagy-Dependent Degradation
of AIM2
Since there are at least three systems of protein degradation
(the proteasome, lysosome, and autolysosome pathways), we
next determined in which pathway TRIM11 induces the degra-
dation of AIM2. We found that TRIM11-mediated degradation
of AIM2 was completely inhibited by the autophagy inhibitors
chloroquine (CQ) or 3-methyladenine (3-MA), as well as lyso-
somal inhibitor ammonium chloride (NH4Cl), but not the
proteasome inhibitor MG132 (Figure 5A). These results indicate
that TRIM11 mediates AIM2 degradation through the autolyso-
some pathway. Indeed, we found that autophagy induced by
starvation or rapamycin promoted degradation of AIM2, while
several inhibitors of autophagy, such as bafilomycin and tuba-
cin, could block the degradation of AIM2 (Figure S3A). The
degradation rate of AIM2 was indeed markedly slowed down
in BECN1-KO HEK293T cells (Figure S3B). In addition, we
found the degradation of AIM2 induced by Earle’s balanced
salt solution (EBSS) was impaired in TRIM11-KO cells (Fig-
ure 5B), indicating that TRIM11 plays a critical role in mediating
autophagy-dependent degradation of AIM2. In addition, we
found that AIM2 localizes into the autolysosome (and co-local-
izes with LC3B) with TRIM11, especially in the presence of
the autophagy inhibitor CQ (Figure 5C). Consistent with these
results, the degradation of AIM2 mediated by TRIM11 was
totally blocked in BECN1-KO or MAP1LC3B-KO HEK293T cells
(Figures 5D and 5E). Together, these results suggest that
TRIM11 mediates AIM2 degradation through the autolysosome
pathway.
Emerging evidence shows that autophagy can distinguish and
direct specific cargos to the lysosome. The selective nature of
autophagy is mainly ensured by different cargo receptors. We
found that AIM2 specifically interacted with p62, but not other
cargo receptors, including NIX, OPTN, NBR1, tollip, or NDP52
(Figure 5F). Interestingly, AIM2 did not interact with other
key proteins in autophagy initiation and elongation, including
members of the ULK1 complex, beclin-1 complex, or ATG5-(D and E) Mouse peritoneal macrophages or human PBMCs were primed with
subjected to immunoprecipitation with anti-TRIM11 and immunoblot analysis.
(F) HEK293T cells were transfected with plasmids expressing FLAG-AIM2WT or m
WCLs were then harvested for immunoprecipitation with anti-FLAG beads and im
(G) 293T cells were transfected with plasmids expressing HA-TRIM11 and its mut
were harvested for immunoprecipitation with anti-FLAG beads and immunoblot
1994 Cell Reports 16, 1988–2002, August 16, 201612, ATG7 (Figures S3C and S3D). These results indicate that
AIM2 is recruited to the autophagosome during its maturation.
Furthermore, we found that TRIM11 also specifically interacted
with p62, but not other autophagy-related proteins (Figures 5G
and 5H), implying that TRIM11 might recruit AIM2 to p62 during
autophagosome maturation.
TRIM11 Recruits AIM2 to p62 for Selective Autophagic
Degradation
To investigate whether TRIM11 recruits AIM2 to the cargo recep-
tor p62, we first examined the association of TRIM11 with AIM2
and p62. We observed an enhanced interaction between
TRIM11 and AIM2 or p62, respectively, upon poly(dA:dT) treat-
ment (Figure 6A). Moreover, confocal microscopic analysis indi-
cated that AIM2 showed little co-localization with p62 in HeLa
cells. However, TRIM11 overexpression enhanced AIM2-p62
co-localization, especially in the presence of the autophagy in-
hibitor CQ (Figure 6B). This observation was further confirmed
by coIP in the presence of NH4Cl (Figure 6C), suggesting that
exogenous TRIM11 enhances AIM2-p62 co-localization and
interaction. To substantiate these findings, we specifically
knocked down TRIM11 using a TRIM11-specific siRNA. The
interaction between AIM2 and p62 was markedly attenuated in
TRIM11-KD cells (Figure 6D). Further, we demonstrated that
the interaction between AIM2 and p62 was almost abrogated
in TRIM11-KO cells (Figure 6E). To define the region of TRIM11
that mediated its interaction with p62, we co-transfected themu-
tants of TRIM11 with p62 in 293T cells, respectively, and found
that the PS domain was necessary for the interaction between
TRIM11 and p62 (Figure S4). Moreover, in TRIM11-KO cells,
we found that the RING and PS domains of TRIM11 were both
critical for p62 binding, indicating that the E3 ligase activity of
TRIM11 is critical for the interaction between p62 and TRIM11
(Figure 6F). Finally, we investigated whether TRIM11 recruited
AIM2 to p62 for degradation and found that TRIM11 cannot
degrade AIM2 in p62-KO HEK293T cells (Figure 6G), indicating
that p62 is critical for selective autophagic degradation of
AIM2 mediated by TRIM11.
Autoregulated Ubiquitination of TRIM11 at Lys 458 Is
Required for Its Interaction with p62
It has been reported that p62 directs ubiquitinated proteins to the
autolysosome for selective degradation mainly through its C-ter-
minal ubiquitin (Ub)-associated domain (UBA) (Walinda et al.,
2014). We thus speculated that TRIM11 mediates the ubiquitina-
tion of AIM2, which is recognized by p62 for degradation. How-
ever, we did not observe any change in AIM2 ubiquitination with
different linkages in the presence of TRIM11 (Figure S5A), sug-
gesting that AIM2 is not a direct substrate of TRIM11. Intrigu-
ingly, our results showed that TRIM11 does not bind to p62
DUBA mutant, indicating that ubiquitination of TRIM11 mayLPS and IFN-g, then treated with poly(dA:dT) (1 mg/l) for 6 hr. Extracts were
utant forms together with HA-TRIM11 and treated with NH4Cl (20 mM) for 6 hr.
munoblot analysis with anti-HA.
ants together with FLAG-AIM2 and treated with NH4Cl (20 mM) for 6 hr. WCLs
analysis with anti-HA.
Figure 4. TRIM11 Induces AIM2 Degradation
(A) Immunoblot analysis (top) of protein extracts of
293T cells transfected with plasmid for FLAG-AIM2
and increasing doses of plasmid for HA-TRIM11
(wedge). RT-PCR analysis ofAIM2mRNA is shown;
GAPDH mRNA (encoding glyceraldehyde phos-
phate dehydrogenase) serves as a loading control.
(B) HEK293T and TRIM11-KO cells were trans-
fected with FLAG-AIM2 for 20 hr and treated with
cycloheximide (CHX) (100 mg/ml) at the indicated
time points. Cell lysates were then collected for
immunoblot.
(C) Immunoblot analysis of TRIM11-inducible THP-
1 macrophages treated with doxycycline (Dox)
(100 ng/ml) for 24 hr and challenged with or without
poly(dA:dT) (1 mg/ml) for 6 hr.
(D) THP-1-derived macrophages were transfected
with control siRNA or TRIM11 siRNA for 48 hr, fol-
lowed by poly(dA:dT) (1 mg/ml) treatment for 6 hr.
Cell lysates were then collected for immunoblot.
(E) Control sgRNA or TRIM11-KO THP-1-derived
macrophages were treated with poly(dA:dT)
(1 mg/ml) at the indicated time points. Cell lysates
were then collected for immunoblot.
(F) Immunoblot analysis of extracts of 293T cells
transfected with plasmids for HA-TRIM11 or its
mutants, together with FLAG-AIM2.
See also Figure S2.play an important role for the interaction between the AIM2-
TRIM11 complex and p62 (Figure 7A). Recently, several TRIMs
have been reported to regulate protein-protein interactions
through their autoregulated poly-ubiquitin chains (Tanji et al.,
2010). We observed that TRIM11 underwent robust poly-ubiqui-
tination upon poly(dA:dT) treatment or HSV-1 infection (Figures
7B and 7C). Next, we tested whether the ubiquitination of
TRIM11 is autoregulated by itself. We generated two enzymatic
inactive mutants, C53A TRIM11 mutant and C56A TRIM11
mutant, and found that the poly-ubiquitination of both CA
TRIM11 mutants was much weaker compared with WT
TRIM11 (Figure 7D), whereas the ubiquitination of C53A or
C56A TRIM11 mutant could be restored in the presence of WT
TRIM11 (Figure 7D). In addition, both CA TRIM11 mutants had
attenuated ability to interact with p62 compared with WT
TRIM11 (Figure 7E). These results suggest that TRIM11 un-
dergoes autoregulated ubiquitination to bind to p62.
Using computer-assisted algorithms, we identified three key
ubiquitination sites in the TRIM11 and substituted Lys169,
Lys366, and Lys458 with arginine to create K169R, K366R,
and K458R mutants of TRIM11, respectively. We found that
the K458R TRIM11 mutant showed reduced auto-ubiquitination
compared to WT TRIM11, but the K169R and K366R TRIM11
mutants did not (Figure 7F). Furthermore, unlike WT TRIM11 or
other mutants, the K458R mutant could no longer bind to p62
(Figure 7G). This finding was further supported by a functional
assay showing that the K458R mutant, as well as the CA enzy-
matic inactive mutants, lost their ability to promote AIM2 degra-
dation (Figure 7H). In addition, we found that auto-ubiquitination
of TRIM11 does not affect its ability to bind to AIM2 (Figure S5B).Taken together, these results suggest that Lys458 in TRIM11 is
an essential residue for TRIM11-mediated auto-ubiquitination,
interaction with p62, and degradation of AIM2.
DISCUSSION
Inflammasomes are involved in the host’s response to specific
pathogens, environmental stimuli, and host cell damage, regu-
lating the activation of caspase-1 and the cleavage of IL-1b
and inducing inflammation (Chen and Ichinohe, 2015). Several
sensors can trigger the formation of inflammasomes, including
NLRP1, NLRP3, NLRP6, NLRP7, NLRP12, NLRC4, IFI16, and
AIM2 (Latz et al., 2013). Overactivation of inflammasomes is
closely correlated with several auto-inflammatory syndromes
and metabolic diseases (Schieber et al., 2015). Therefore, a bet-
ter understanding of how inflammasomes are regulated may
shed light on more effective treatments for inflammasome-asso-
ciated diseases. Several reports demonstrated that post-trans-
lational modification (PTM) plays a critical role in regulating in-
flammasome activation (Meng et al., 2015). For example, the
ubiquitination of NLRP3 is involved in regulating inflammasome
activation. BRCC3, a deubiquitinating enzyme, is a critical regu-
lator of the NLRP3 inflammasome, as it promotes the deubiqui-
tination of the LRR domain of NLRP3 and characterizes NLRP3
as a substrate for the cytosolic BRCC3-containing BRISC com-
plex (Py et al., 2013). In addition, phosphorylation is critical for
NLRC4 inflammasome function (Qu et al., 2012). The phosphor-
ylation-defective NLRC4 S533A mutant fails to recruit pro-cas-
pase-1 and does not assemble inflammasome specks during
Salmonella typhimurium infection. In addition, several studiesCell Reports 16, 1988–2002, August 16, 2016 1995
Figure 5. TRIM11 Mediates Autophagy-Dependent Degradation of AIM2
(A) Immunoblot analysis of extracts of 293T cells transfected with plasmids for FLAG-AIM2 and HA-TRIM11 and treated with DMSO (vehicle), MG-132 (10 mM),
3-MA (10 mM), CQ (50 mM), or NH4Cl (20 mM) for 6 hr.
(B) Wild-type (WT) and TRIM11-KO HEK293T cells were transfected with HA-AIM2 for 20 hr and treated with EBSS for 4 hr. Cell lysates were then collected for
immunoblot.
(legend continued on next page)
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also showed that many proteins could regulate inflammasome
activation via an indirect manner, such as TRIM30. TRIM30 sup-
presses NLRP3 inflammasome by attenuating reactive oxygen
species production in a RING-independent manner (Hu et al.,
2010). However, the precise regulation of AIM2 inflammasome
is still poorly understood compared with other inflammasomes.
Here, we defined a critical role of the E3 ubiquitin ligase
TRIM11 in the negative regulation of AIM2 inflammasome activa-
tion. Through overexpression, KD, and KO experiments, we con-
sistently demonstrate that TRIM11 targets AIM2 for its degrada-
tion via selective autophagy.
Autophagy is an evolutionarily conserved catabolic process
that refers to any cellular degradative pathway that is essential
for survival, differentiation, development, and homeostasis.
Autophagy has long been considered an unselective process
for bulk degradation of long-lived proteins and organelles. How-
ever, a number of recent reports presented mounting evidence
of selective autophagic degradation of protein inclusions caused
by aggregate-prone or misfolded proteins (Jia et al., 2015;
Johansen and Lamark, 2011; Matsumoto et al., 2011). Cargo
receptor proteins such as p62, NBR1 (next to BRCA1 gene 1 pro-
tein), and optineurin serve as crucial adaptors between LC3-
decorated autophagosomes and ubiquitin-conjugated protein
aggregates (Fan et al., 2010). Nevertheless, the present para-
digms of selective autophagy in mammalian cells cannot fully
explain the specificity and selectivity of autophagic degradation.
In this study, we found that TRIM11 acts as a secondary receptor
to recruit p62 in an ubiquitin-dependent nature and assist
AIM2 delivery to autophagosomes for selective autophagic
degradation. Knockdown or knockout of TRIM11 markedly at-
tenuates the interaction between AIM2 and p62. Thus, our find-
ings provide insight into the crosstalk between autophagy and
inflammasomes.
Based on these experimental data, we proposed a working
model to illustrate how TRIM11 negatively regulates AIM2 in-
flammasome activation through facilitating the AIM2-p62 inter-
action (Figure S6). AIM2 interacts with the PS domain of
TRIM11 in a stimuli-enhanced manner upon poly(dA:dT) treat-
ment or DNA virus infection. In themeantime, TRIM11 undergoes
auto-polyubiquitination on K458 through its own E3 ligase activ-
ity. In turn, p62 recognizes the ubiquitinated TRIM11-AIM2 pro-
tein complex and assists with the delivery of AIM2 aggregates to
autophagosomes for degradation. Since the autophagy flux is
also enhanced by AIM2 activation (Saiga et al., 2015), the degra-
dation of AIM2 by TRIM11 is accelerated by DNA virus infection.
Together, this process leads to the downregulation of AIM2 in-
flammasome activity.(C) HeLa cells transfected with CFP-AIM2,GFP-LC3B, or RFP-TRIM11were challe
4% (wt/vol) paraformaldehyde and subjected for confocal microscopy analysis.
(D) WT and BECN1 KO HEK293T cells were transfected with FLAG-AIM2 and
collected for immunoblot.
(E) Wild-type (WT) and MAP1LC3B KO HEK293T cells were transfected with FLA
lysates were collected for immunoblot.
(F) Co-immunoprecipitation and immunoblot analysis of HEK293T cells transfect
FLAG-NIX, FLAG-OPTN, FLAG-NBR1, FLAG-Tollip, FLAG-NDP52, respectively.
(G and H) Co-immunoprecipitation and immunoblot analysis of HEK293T cells tra
components including, FLAG-tagged p62, ULK1, Atg13, beclin-1, Atg14, UVRAG
See also Figure S3.Besides its function in pathogen recognition, AIM2 also plays
an important role in tumorigenesis, such as melanomas, colo-
rectal cancers, and prostate tumors. Mice lacking Aim2 develop
more precancerous intestinal polyps and colon tumors than WT
mice (Wilson et al., 2015). Furthermore, autophagy is thought to
play a critical role in cancer, where it sustains tumor metabolism,
growth, and survival via nutrient recycling (Guo et al., 2013). Our
findings may provide insight into inflammasome and tumorigen-
esis, by which TRIM11 degrades AIM2 and thus promotes tumor
growth. The connection between TRIM11 and tumorigenesis
needs further investigation. Overall, our work demonstrates
that TRIM11 acts as a negative regulator that targets AIM2 to au-
tophagosomes for degradation in a p62-dependent manner.
These findings may provide additional therapeutic targets for
future anti-inflammatory and cancer therapies.
EXPERIMENTAL PROCEDURES
Cells
HEK293T and HeLa cells were maintained in DMEM (Hyclone) with 10% (vol/
vol) fetal bovine serum (Gibco) and 1% L-glutamine (Gibco). THP-1 cells were
cultured in RPMI 1640 medium (Gibco) supplemented with 10% (vol/vol) fetal
bovine serum and 1% L-glutamine. THP-1 cells were differentiated into mac-
rophages by treatment with 100 ng/ml phorbol-12-myristate-13-acetate
(PMA; Sigma) for 12 hr and cultured with RPMI 1640. BMDMs or BMDCs
were derived from bone marrow of 18- to 20-g C57BL/6 mice (Guangdong
Medical Laboratory Animal Center) and cultured for 6–8 days with 100 ng/ml
macrophage colony-stimulating factor (PeproTech) or 20 ng/ml granulocyte-
macrophage colony-stimulating factor (PeproTech).
Reagents and Antibodies
Lipopolysaccharide (LPS), nigericin, and silica were purchased from Sigma.
Poly(I:C), ATP, poly(dA:dT), MSU, alum, MDP, and CPPD were purchased
from Invivogen. To induce starvation, cells were washed with PBS and incu-
bated in EBSS (Gibco). Rapamycin, bafilomycin A1, CQ, and NH4Cl were pur-
chased from Sigma. Goat anti-rabbit (sc-2004), goat anti-mouse (sc-2005),
anti-ubiquitin (P4D1), and anti-TRIM11 (sc-366347) were purchased from
Santa Cruz Biotechnology. Anti-caspase-1 (#2225), anti-IL-1b (3A6), and
anti-beclin-1 (#3738) were purchased from Cell Signaling Technology. Horse-
radish peroxidase (HRP)-anti-FLAG (M2) (A8592) and anti-b-actin (A1978)
were purchased from Sigma. HRP-anti-hemagglutinin (clone 3F10) and anti-
c-Myc-HRP (11814150001) were purchased from Roche Applied Science.
Anti-AIM2 (ab93015) was purchased from Abcam. Anti-p62 (18420-1-AP)
was purchased from Proteintech.
Plasmids and siRNA Transfection
Plasmids for HA-,Myc-, or FLAG-tagged TRIM11, AIM2, and p62 and their frag-
ment were cloned into thepcDNA3.1 vector for transient expression. Chemically
synthesized 21-nt siRNA duplexes were obtained from TranSheepBio and
transfected using Lipofectamine RNAiMAX (Invitrogen) according to the manu-
facturer’s instructions. The following RNA oligonucleotides were used in thisngedwith chloroquine (CQ) (50 mM) for 6 hr. Subsequently, cells were fixedwith
Scale bars, 20 mm.
increasing doses of plasmids for HA-TRIM11 (wedge), and cell lysates were
G-AIM2 and increasing doses of plasmids for Myc-TRIM11 (wedge), and cell
ed with HA-AIM2 along with expression vectors for cargo receptor FLAG-p62,
nsfected with HA-TRIM11 along with expression vectors for certain autophagic
(G), Atg12, Atg7, Atg5, LC3B, or Atg4B (H).
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Figure 6. TRIM11 Recruits AIM2 to p62 for Selective Autophagic Degradation
(A) Extracts of THP-1-derived macrophages treated with 1 mg/ml poly(dA:dT) for 6 hr were subjected to immunoprecipitation with anti-TRIM11 and immunoblot
with indicated antibodies.
(legend continued on next page)
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study: control siRNA, 50-GUUAUCGCAACGUGUCACGUA-30; TRIM11 siRNA1,
50-GGGAGAACGUGAACAGGAATT-30; TRIM11 siRNA 2, 50-GAGAGUAGAU
GUCCUAUAATT-30; AIM2 siRNA 1, 50-UAUGGUGCUAUGAACUCCAGAU
GUC-30; AIM2 siRNA 2, 50-UUUCAGCUUGACUUAGUGGCUUUGG-30; IFI16
siRNA 1, 50-CCACAATCTACGAAATTCA-30; and IFI16 siRNA 2, 50-AAGAA
CATTGTTCTACTAA-30.
Virus Infection
Herpes simplex virus type 1 (HSV-1, KOS strain) was kindly provided by Dr.
Guoying Zhou (Guangzhou Medical University), and cells were infected at
various MOIs.
The Smith strain of mCMV was propagated in vivo in the salivary glands
of BALB/c mice. Infected salivary gland homogenates were diluted in
Hank’s balanced salt solution, and mice were inoculated intraperitoneally
with 1 3 106 plaque-forming units.
Generation of TRIM11-Inducible and Knockout Cell Lines
For TRIM11-inducible expression, lentiviral particles were produced by trans-
fecting HEK293T cells with pL-Teton3G-iZ-TRIM11. THP-1 cells were infected
by incubation with lentivirus-containing supernatant for 48 hr. To generate
TRIM11-KO and BECN1-KO 293T cells, target sequences were cloned into
pLentiCRISPRv2 by cutting with BsmBI as previous described (Jin et al.,
2016). The following target sequences were used: hBECN 1 target 1, 50-GGG
TCTCTCCTGGTTTCGCC-30; hp62 target 1, 50-TCAGGAGGCGCCCCGCA
ACA-30; hMAP1LC3B target 1, 50- TTCAAGCAGCGCCGCACCTT-30; hTRIM11
target 1, 50-GATCCGGTGATGACCGACTG-30; hTRIM11 target 2, 50-GGCACT
CGGGGCACGCGTAC-30; mTrim11 target 1, 50-GTGCCCCATCTGCGAGC
GTT-30.
Bone Marrow Transfer
BM cells were isolated from 8- to 10-week-old WT C57BL/6 donor mice and
then transduced with Cas9/CRISPR-GFP sgRNA or Cas9/CRISPR-Trim11
sgRNA packaged with the D8.9 VSVG lentivirus expression system. 6 hr later,
the supernatant were changed with 1640 complete culture medium and set for
overnight. 8- to 10-week-old age- and sex-matched WT C57BL/6 recipients
were irradiated with 900 cGy and randomly separated into two groups and
intravenously injected with 5 3 106 GFP sgRNA or Trim11 sgRNA transduced
BM cells per mouse, respectively, 24 hr later. The reconstituted mice were
used 7–9 weeks later. C57BL/6 mice were housed under temperature-
controlled (22 ± 1C) and light-controlled (a light cycle of 14 hr light: 10 hr
dark) conditions in the specific pathogen-free (SPF) animal facility of Sun
Yat-sen University. The Institutional Animal Care and Use Committee of Sun
Yat-sen University approved all of the experimental protocols concerning
the handling of mice.
qRT-PCR
Total RNA was extracted from the cells using TriZol reagent (Invitrogen) ac-
cording to the manufacturer’s instructions. For RT-PCR analysis, cDNA was
generated with HiScript II Q RT SuperMix for qPCR (+gDNA wiper) (Vazyme,
R223-01) and analyzed by real-time qRT-PCR using 2 3 RealStar SYBR
Mixture (Genestar). All data were normalized to GAPDH expression. Primer
sequences were as follows: GAPDH, sense: 50-CGGAGTCAACGGATTTGG(B) HeLa cells transfected with GFP-AIM2 or RFP-TRIM11 and FLAG-p62 were ch
with 4% (wt/vol) paraformaldehyde and stained with anti-FLAG-CFP antibody an
(C) HEK293T cells were transfected with HA-AIM2 and FLAG-p62, with or witho
collected for immunoprecipitation with anti-FLAG beads, followed by immunoblo
(D) HEK293T cells were transfected with TRIM11 siRNA, HA-p62, and FLAG-AI
immunoprecipitation with anti-FLAG beads, followed by immunoblot with anti-H
(E) Control sgRNA and TRIM11-KO 293T cells were transfected with HA-p62 an
immunoprecipitation with anti-FLAG beads, followed by immunoblot with anti-H
(F) Immunoblot analysis of extracts of TRIM11-KOHEK293T cells transfectedwith
were collected for immunoprecipitation with anti-FLAG beads, followed by immu
(G) Wild-type (WT) and p62-KO HEK293T cells were transfected with FLAG-AIM2
collected for immunoblot.
See also Figure S4.TC-30, anti-sense: 50-GACAAGCTTCCCGTTCTCAG-30; AIM2, sense: 50-AG
CAAGATATTATCGGCACAGTG-30, anti-sense, 50-GTTCAGCGGGACATTAA
CCTT-30; TRIM11, sense: 50-GAGAACGTGAACAGGAAGGAG-30; anti-sense:
50-CCATCGGTGGCACTGTAGAA30; IL-6, sense: 50-AGAGGCACTGGCA
GAAAACAAC-30; anti-sense: 50-AGGCAAGTCTCCTCATTGAATCC-30; IL-1b,
sense: 50-ATGATGGCTTATTACAGTGGCAA-30, anti-sense: 50-GTCGGAGA
TTCGTAGCTGGA-30; TNF-a, sense: 50-CCAGACCAAGGTCAACCTCC-30,
and anti-sense: 50-CAGACTCGGCAAAGTCGAGA-30.
Immunoprecipitation and Immunoblot Analysis
For immunoprecipitation, whole-cell extracts were prepared after transfection
or stimulation with appropriate ligands, followed by incubation overnight with
the appropriate antibodies plus anti-FLAG, anti-HA beads (Sigma) or Protein
A/G beads (Pierce). Beads were washed five times with low-salt lysis buffer,
and immunoprecipitates were eluted with 33 SDS Loading Buffer (Cell
Signaling Technology) and resolved by SDS-PAGE. Proteins were transferred
to polyvinylidene fluoride (PVDF) membranes (Bio-Rad) and further incubated
with the appropriate antibodies. The LumiGlo Chemiluminescent Substrate
System (KPL) was used for protein detection.
Measurement of Active Caspase-1 by Fluorochrome-Labeled
Inhibitors of Caspases Assay
The levels of active caspase-1 were quantified using a fluorescent probe (fluo-
rochrome -labeled inhibitors of caspases [FLICA] FAM-YVAD-FMK, Immuno-
Chemistry Technologies) that specifically recognized active caspase-1. Fluo-
rescence intensity was measured with flow cytometry (Guava EasyCyteHT).
Cytotoxicity Assay
Relevant cells were treated as indicated. Cell death wasmeasured by a lactate
dehydrogenase (LDH) assay using CytoTox 96 Non-Radioactive Cytotoxicity
Assay kit (Promega).
Fluorescence Microscopy
Cells were cultured on a glass-bottom dish and directly observed. For exam-
ination by immunofluorescence microscopy, cells grown on gelatin-coated
coverslips were fixed with 4% paraformaldehyde, permeabilized using
50 mg/ml digitonin, and then stained with specific antibodies. Colocalization
images were examined under a Zeiss LSM 700 confocal microscope equipped
with a 3100 (numerical aperture 1.4) oil-immersion objective.
Statistical Analyses
Data are presented asmean ± SDwhen indicated, and the Student’s t test was
used for all statistical analyses with GraphPad Prism 5 software. Differences
between groups were considered significant when the p value was less than
0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online http://dx.doi.org/
10.1016/j.celrep.2016.07.019.allenged with chloroquine (CQ) (50 mM) for 6 hr. Subsequently, cells were fixed
d subjected to confocal microscopy analysis.
ut Myc-TRIM11, and treated with NH4Cl (20 mM) for 6 hr. Cell extracts were
t with anti-HA antibody.
M2 and treated with NH4Cl (20 mM) for 6 hr. Cell extracts were collected for
A antibody.
d FLAG-AIM2 and treated with NH4Cl for 6 hr. Cell extracts were collected for
A antibody.
plasmids for HA-TRIM11, or its mutants, together with FLAG-p62. Cell extracts
noblot with anti-HA antibody.
and increasing doses of plasmid for HA-TRIM11 (wedge), and cell lysates were
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Figure 7. Autoregulated Ubiquitination of TRIM11 at Lys 458 Is Required for Its Interaction with p62
(A) HEK293T cells were transfected with HA-TRIM11 together with FLAG-p62 or FLAG-p62DUBA. Cell lysates were immunoprecipitated by anti-FLAG beads and
immunoblotted with anti-HA.
(B and C) HEK293T cells were transfected with plasmids for FLAG-TRIM11, followed by poly(dA:dT) (1 mg/ml) treatment for 6 hr (B) or HSV-1 infection (MOI = 0.1,
12 hr) (C). Cell extracts were collected for immunoprecipitation with anti-FLAG beads, followed by immunoblot with the indicated antibodies.
(legend continued on next page)
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